31 August - 04 September 2019, Paris - France

Session Details

Poster Session 6: Coronary artery disease inflammation
Tue 03 Sep 08:30 - 12:30 European Society of Cardiology Poster Session, Abstract-based Programme Posters - Poster Area
Learning Objectives: Posters are on display from 08:30 – 12:30. Presenters will be by their poster during the coffee break from 10:05 and 10:55 for posters viewing time.

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Related documents
08:30P5505Inflammation implicated in the aetiology of major vascular and non-vascular diseases in East AsiansMohd Anisul KARIM (Dhaka, Bangladesh)
08:30P5506Proprotein convertase subtilisin/kexin 9 (PCSK9) and lipopolysaccharide (LPS) in patients with atrial fibrillation. A biomarker post-hoc analysis from the ATHERO-AF cohort.Pasquale PIGNATELLI SPINAZZOLA (Poggio Nativo, Italy)
08:30P5507Growth differentiation factor-15 and mortality in suspected or known coronary heart disease patients with chronic kidney disease: a subanalysis of the ANOX studyDaisuke TAKAGI (Kyoto-Shi, Japan)
08:30P5508Impact of CD14++CD16+ monocytes on coronary plaque vulnerability assessed by optical coherence tomography in coronary artery disease patientsHiroyuki YAMAMOTO (Kobe, Japan)
08:30P5509Apabetalone (RVX-208) inhibits key drivers of vascular inflammation, calcification, and plaque vulnerability through a BET-dependent epigenetic mechanismEwelina KULIKOWSKI (Calgary, Canada)
08:30P5510High plasma sRAGE is associated with slower carotid intima media thickness progression and lower risk for first-time coronary events and mortalityHelena GRAUEN LARSEN (Bunkeflostrand, Sweden)
08:30P5511Markers of vascular damage in cardiovascular events prediction: results from cluster analysisSergey DAVYDOV (Moscow, Russian Federation)
08:30P5513Relation of thyroid hormones level to the extent of myocardial injury in patients with acute coronary syndromeHala BADRAN (Tanta, Egypt)
08:30P5514Impact of pro-inflammatory conditions on myocardial infarction with non-obstructive coronary arteries.Maria Jesus ESPINOSA PASCUAL (Madrid, Spain)
08:30P5515Circulating galectin 1 is associated with severity of coronary artery disease and adverse cardiovascular events in patients undergoing coronary angiographyRuey-Hsing CHOU (Taipei, Taiwan)